‌

US Patent 10034873 C-met modulator pharmaceutical compositions

Patent 10034873 was granted and assigned to Exelixis Ltd on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Jo Ann Wilson0

Khalid Shah0

Date of Patent

July 31, 2018

Patent Application Number

15612703

Date Filed

June 2, 2017

Patent Citations Received

US Patent 12128039 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds

0

US Patent 11760726 Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

US Patent 11433064 Methods of using c-Met modulators

US Patent 12064430 Kinase inhibitor salts and compositions thereof

0

US Patent 12064428 Kinase inhibitor salts and compositions thereof

0

US Patent 11504363 Method of treating cancer and bone cancer pain

0

US Patent 10273211 Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

US Patent 10501418 Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

0

...

Patent Primary Examiner

Michael B. Pallay

Patent abstract

Pharmaceutical compositions and unit dosage forms comprising Compound I are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10034873 C-met modulator pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.